Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 701 - 710 of 764 studies

Varying Keyhole Limpet Haemocyanin-adjuvant dose combinations to explore the immune response: a human challenge study

Pilot study of the acceptability and feasibility of a 360-degree immersive PET/CT suite video tour intervention for the reduction of anxiety in PET/CT patients

The creation of a national UK database for patients with all myasthenic syndromes under NHS hospital care using Research Electronic Data Capture (REDCap)

Cancer and neoplasms

An Open-Label, 3-Arm, Multicenter, Randomized Phase 3 Study To Evaluate The Efficacy And Safety Of Elranatamab (Pf-06863135) Monotherapy And Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone In Participants With Relapsed/Refractory Multiple Myeloma Who Have Received At Least 2 Prior Lines Of Therapy Including Lenalidomide And A Proteasome Inhibitor (MAGNETISMM-5)

Renal and Urogenital

A Phase 1b, Multicenter, Open Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant (AT-1501-K102)

Cancer and neoplasms

A Phase Ib Open-Label, Multi-center Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia (BO43243)

Cancer and neoplasms

A Phase 1, Dose Escalation, and Cohort Expansion Study Evaluating NX-5948, a Bruton’s Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies.

Infection

International, multi-centre, observational study to determine the molecular heterogeneity of RSV in children INFORM RSV (INFORM RSV)

VoLunteEr scanning to develop and optimise mAgnetic ResonaNce imaging (LEARN)

Oxford Gastrointestinal Cohort (RENEWAL)